1. An immuno-food composition for temporarily preventing or attenuating bone marrow paralysis or neutropenia caused by anticancer therapy, including:! at least one immunostimulating agent and a pharmaceutically acceptable carrier, and at least one immunostimulating agent is able to protect innate and adaptive immune functions and normal physiology of immune cells, while maintaining immune functions and normal physiology leads to improved tolerance and increased effectiveness of anti-cancer therapy and temporary preventing or ameliorating bone marrow paralysis or neutropenia in a subject. ! 2. The immuno-food composition according to claim 1, in which at least one immunostimulating agent is able to optimize the effects and increase the immunocompetence of immune cells weakened by anti-cancer therapy. ! 3. The immuno-food composition of claim 1, wherein the at least one immunostimulating agent is capable of inducing at least one immunogenic determinant in immune cells. ! 4. The immune food composition according to claim 1, in which the immune cells are antigen-presenting cells selected from the group consisting of macrophages, dendritic cells, dendritic killer cells, antigen-specific cytolytic lymphocytes, cytotoxic T cells CD8 + (CTL) and normal killer cells . ! 5. The immuno-food composition according to claim 1, in which at least one immunostimulating agent improves the function of presentation of antigens, congenital cell destruction and antigen-specific destruction of cancer cells in antigen-presenting cells.1. Иммунопищевая композиция для временного предупреждения или ослабления вызванного противораковой терапией паралича костного мозга или нейтропении, включающая: ! по меньшей мере одно иммуностимулирующее средство и фармацевтически приемлемый носитель, причем по меньшей мере одно иммуностимулирующее средство способно предохранять врожденные и адаптивные иммунные функции и нормальную физиологию иммунных клеток, при этом сохранность иммунных функций и нормально
